期刊
OPEN FORUM INFECTIOUS DISEASES
卷 4, 期 2, 页码 -出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/ofid/ofx078
关键词
Clostridium difficile; pharmaceutical costs; vancomycin
资金
- US Department of Veterans Affairs Research Service
Vancomycin is an increasingly important option for the treatment of Clostridium difficile infection, but economic barriers to its use remain significant in the outpatient setting. Generic vancomycin capsules are still inexplicably expensive and not universally covered by insurers. This report highlights the potential adverse consequences of cost-related nonadherence to vancomycin therapy and the challenges that clinicians face when prescribing oral vancomycin.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据